key: cord-0932770-64t2bllo
authors: Tsonas, Anissa M.; Botta, Michela; Horn, Janneke; Brenner, Michael J.; Teng, Marita S.; McGrath, Brendan A.; Schultz, Marcus J.; Paulus, Frederique; Neto, Ary Serpa
title: Practice of Tracheostomy in Patients with Acute Respiratory Failure related to COVID–19 – insights from the PRoVENT–COVID study
date: 2021-09-20
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2021.08.012
sha: 21af1f082064437e24dbd8fcc97b5369b82b4f74
doc_id: 932770
cord_uid: 64t2bllo

OBJECTIVE: Invasively ventilated patients with acute respiratory failure related to coronavirus disease 2019 (COVID–19) potentially benefit from tracheostomy. The aim of this study was to determine the practice of tracheostomy during the first wave of the pandemic in 2020 in the Netherlands, to ascertain whether timing of tracheostomy had an association with outcome, and to identify factors that had an association with timing. METHODS: Secondary analysis of the ‘PRactice of VENTilation in COVID–19’ (PRoVENT–COVID) study, a multicenter observational study, conducted from March 1, 2020 through June 1, 2020 in 22 Dutch intensive care units (ICU) in the Netherlands. The primary endpoint was the proportion of patients receiving tracheostomy; secondary endpoints were timing of tracheostomy, duration of ventilation, length of stay in ICU and hospital, mortality, and factors associated with timing. RESULTS: Of 1023 patients, 189 patients (18.5%) received a tracheostomy at median 21 [17 to 28] days from start of ventilation. Timing was similar before and after online publication of an amendment to the Dutch national guidelines on tracheostomy focusing on COVID–19 patients (21 [17–28] vs. 21 [17–26] days; P=NS). Tracheostomy performed ≤21 days was independently associated with shorter duration of ventilation (median 26 [21 to 32] vs. 40 [34 to 47] days) and higher mortality in ICU (22.1% vs. 10.2%), hospital (26.1% vs. 11.9%) and at day 90 (27.6% vs. 14.6%). There were no patient demographics or ventilation characteristics that had an association with timing of tracheostomy. CONCLUSIONS: Tracheostomy was performed late in COVID–19 patients during the first wave of the pandemic in the Netherlands and timing of tracheostomy possibly had an association with outcome. However, prospective studies are needed to further explore these associations. It remains unknown which factors influenced timing of tracheostomy in COVID–19 patients.

Objective 2 Invasively ventilated patients with acute respiratory failure related to coronavirus 3 disease 2019 (COVID- 19) potentially benefit from tracheostomy. The aim of this study 4 was to determine the practice of tracheostomy during the first wave of the pandemic in 5 2020 in the Netherlands, to ascertain whether timing of tracheostomy had an 6 association with outcome, and to identify factors that had an association with timing. 7 Methods 8 Secondary analysis of the 'PRactice of VENTilation in COVID-19' (PRoVENT-COVID) 9 study, a multicenter observational study, conducted from March 1, 2020 through June 1, 10 2020 in 22 Dutch intensive care units (ICU) in the Netherlands. The primary endpoint 11 was the proportion of patients receiving tracheostomy; secondary endpoints were timing 12 of tracheostomy, duration of ventilation, length of stay in ICU and hospital, mortality, and 13 factors associated with timing. 14 

Of 1023 patients, 189 patients (18.5%) received a tracheostomy at median 21 [17 to 28] 16 days from start of ventilation. Timing was similar before and after online publication of 17 an amendment to the Dutch national guidelines on tracheostomy focusing on COVID- 18 19 patients (21 [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] vs. 21 [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] days; P=NS). Tracheostomy performed ≤21 days 19 was independently associated with shorter duration of ventilation ( vs. 11.9%) and at day 90 (27.6% vs. 14.6%). There were no patient demographics or 22 ventilation characteristics that had an association with timing of tracheostomy. Tracheostomy is a frequently performed intervention in critically ill patients who require 31 prolonged invasive ventilation, facilitating liberation from the ventilator and possibly 32 reducing sedation needs due to increased patient comfort 1, 2 . Patients with acute 33 respiratory failure related to coronavirus disease 2019 (COVID-19) often need 34 prolonged ventilation [3] [4] [5] and therefore, a substantial proportion of COVID-19 patients 35 might benefit from tracheostomy 6 . 36 It is uncertain how long after start of invasive ventilation tracheostomy should be 37 performed, in both non COVID-19 [7] [8] [9] and COVID-19 patients. Early in the pandemic, 38 adjusted tracheostomy guidelines for COVID-19 patients were released worldwide 10,11 , 39 with over 90% of these adjusted guidelines advising to wait at least 14 days after 40 intubation before performing a tracheostomy 11 . Factors in favor of delaying 41 tracheostomy included an expected decrease in risk of contamination of healthcare 42 workers, and high risk of dangerous deteriorations in gas exchange during the 43 procedure 12 . Timing could also have been influenced by shortages in personal 44 protection equipment (PPE) and tracheostomy kits, and lack of experienced health care 45 workers able to perform or guide the procedure. 46 The practice of tracheostomy in invasively ventilated patients with acute 47 respiratory failure related to COVID-19 in the Netherlands is largely unknown. We 48 explored the database of the 'PRactice of VENTilation in COVID-19' (PRoVENT-49 COVID) study, which contains epidemiological characteristics, granular ventilation data, 50 and outcomes of more than 40% of all COVID-19 patients who needed invasive 51 ventilation during the first 3 months of the outbreak in the Netherlands 13 . The aim of this 52 study was to determine the practice of tracheostomy and to ascertain whether timing of 53 tracheostomy had an association with duration of ventilation, length of stay and 54 mortality. We also aimed to identify factors that had an association with timing of 55 tracheostomy. The primary endpoint of this analysis was incidence of tracheostomy. Secondary 71 endpoints were timing of tracheostomy (counted as the number of days between start of 72 invasive ventilation and tracheostomy procedure), outcomes including duration of 73 ventilation, ICU-and hospital -length of stay (LOS), and ICU-, hospital-, and day 28-74 and day 90-mortality, and factors associated with timing. 75 National Dutch guidelines on tracheostomy 76 Before the pandemic, Dutch guidelines regarding tracheostomy practice in invasively 77 ventilated ICU patients advised to 'consider a tracheostomy as soon as it is apparent 78 that weaning from artificial ventilation is unlikely to happen within 2 weeks after 79 endotracheal intubation', and also 'because this prediction is difficult, it is advised to 80 generally delay the procedure until at least 10 days after intubation' 14 predictors, when present in less than 5% of the patients, were imputed by the median. 129 In a post hoc analysis, we also examined whether the abovementioned variables 130 were independently associated with performance of tracheostomy. 131 All analyses were conducted in R v.4.0.2 (R Foundation, Vienna, Austria) and 132 significance level was set at 0.05. (Figure 1) . 155 Compared to patients who were tracheostomized >21 days, patients who were 156 tracheostomized ≤21 days were ventilated with a higher tidal volume and had higher 157 respiratory compliance and lower baseline plasma creatinine at baseline ( Table 1) . 158 Tracheostomy ≤21 days was independently associated with shorter duration of 159 ventilation, but higher ICU-, hospital-and 90-day mortality (Table 2 and Figure 2 ). 160 Factors associated with timing and performance of tracheostomy 

The role of tracheostomy in weaning from mechanical ventilation

The Changing Role for Tracheostomy in Patients Requiring Mechanical Ventilation

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2

Admitted to ICUs of the Lombardy Region, Italy

Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease

Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: 14. Fikkers BG

Tracheostomy on the intensive care unit for adult patients

NVIC tracheotomieprotocol COVID-19 (definitief

Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries

Acute kidney injury in critically ill patients with COVID-19

Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review

ps defined by the median timing of this cohort; group tracheostomized after 21 days is the reference. ssed in the first four days of ventilation.istribution hazard ratio from a Fine-Gray competing risk model with death before extubation in 28 days treated as a competing risk and with center as clustering effect.s ratio from a mixed-effect generalized linear model with a binomial distribution and with center as random effect.rd ratio from a (shared-frailty) Cox proportional hazard model (for the ICU and hospital length of stay analyses, all patients who died prior to discharge were assigned the um length of stay to account for death as a competing risk in this model) with center as frailty. P value for the Schoenfeld residuals; < 0.001 (ICU length of stay); < 0.001 ital length of stay); < 0.001 (90-day mortality) 255 256